Tianjin Zhongxin Pharmaceutical Group Corp Ltd Cash Flow-to-Debt Ratio
Tianjin Zhongxin Pharmaceutical Group Corp Ltd cash flow-to-debt ratio. Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of CN¥110.78 Million could theoretically repay 0% of its total liabilities (CN¥2.56 Billion) in one year. Check 600329 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)
Cash flow-to-debt ratio of Tianjin Zhongxin Pharmaceutical Group Corp Ltd from 2001 to 2024. Historical debt coverage capacity for Tianjin Zhongxin Pharmaceutical Group Corp Ltd across 24 annual periods. Check 600329 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Cash Flow-to-Debt Ratio by Year (2001–2024)
Tianjin Zhongxin Pharmaceutical Group Corp Ltd cash flow-to-debt ratio by year from 2001 to 2024. Year-by-year debt coverage analysis for Tianjin Zhongxin Pharmaceutical Group Corp Ltd. For the full cash flow conversion analysis, see Tianjin Zhongxin Pharmaceutical Group Co cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | CN¥924.67 Million | CN¥2.92 Billion | ▲ +65.0% |
| 2023 | 0.19x | CN¥688.49 Million | CN¥3.58 Billion | ▲ +2.2% |
| 2022 | 0.19x | CN¥677.25 Million | CN¥3.61 Billion | ▼ -43.7% |
| 2021 | 0.33x | CN¥852.40 Million | CN¥2.55 Billion | ▲ +16.0% |
| 2020 | 0.29x | CN¥671.42 Million | CN¥2.33 Billion | ▲ +34.7% |
| 2019 | 0.21x | CN¥495.49 Million | CN¥2.32 Billion | ▲ +25.1% |
| 2018 | 0.17x | CN¥350.14 Million | CN¥2.05 Billion | ▲ +8679.3% |
| 2017 | 0.00x | CN¥-3.97 Million | CN¥2.00 Billion | ▼ -101.0% |
| 2016 | 0.20x | CN¥419.90 Million | CN¥2.06 Billion | ▲ +11.1% |
| 2015 | 0.18x | CN¥360.58 Million | CN¥1.96 Billion | ▲ +59.4% |
| 2014 | 0.12x | CN¥286.85 Million | CN¥2.49 Billion | ▲ +45.0% |
| 2013 | 0.08x | CN¥213.44 Million | CN¥2.69 Billion | ▲ +717.4% |
| 2012 | 0.01x | CN¥20.81 Million | CN¥2.14 Billion | ▼ -89.2% |
| 2011 | 0.09x | CN¥173.88 Million | CN¥1.94 Billion | ▲ +12.9% |
| 2010 | 0.08x | CN¥139.04 Million | CN¥1.75 Billion | ▲ +79.0% |
| 2009 | 0.04x | CN¥83.41 Million | CN¥1.88 Billion | ▼ -43.8% |
| 2008 | 0.08x | CN¥155.77 Million | CN¥1.97 Billion | ▲ +734.4% |
| 2007 | 0.01x | CN¥20.13 Million | CN¥2.13 Billion | ▲ +170.7% |
| 2006 | -0.01x | CN¥-28.08 Million | CN¥2.10 Billion | ▼ -110.8% |
| 2005 | 0.12x | CN¥261.91 Million | CN¥2.11 Billion | ▲ +2310.9% |
| 2004 | 0.01x | CN¥10.50 Million | CN¥2.04 Billion | ▼ -86.8% |
| 2003 | 0.04x | CN¥76.57 Million | CN¥1.96 Billion | ▼ -72.5% |
| 2002 | 0.14x | CN¥187.60 Million | CN¥1.32 Billion | ▲ +6.3% |
| 2001 | 0.13x | CN¥157.73 Million | CN¥1.18 Billion | — |